Composite Government Tracker Insider Trading Hedge Funds Red Flags Financials

Financials

CRSP

CRISPR Therapeutics AG · Biological Products, (No Diagnostic Substances)

Financials Score

★★★★★

Metrics Available8 / 10

You vs. Peer Average

Operating Margin

CRSP

-18933.7%

Peers

26.7%

Net Margin

CRSP

-16569.8%

Peers

18.9%

Revenue Growth (YoY)

CRSP

-90.6%

Peers

2.4%

Earnings Growth (YoY)

CRSP

-58.8%

Peers

40.2%

Return on Equity

CRSP

-30.3%

Peers

3.5%

Return on Assets

CRSP

-25.7%

Peers

4.4%

Current Ratio

CRSP

13.32x

Peers

3.39x

FCF Margin

CRSP

-9855.5%

Peers

24.1%